Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Middle East & Africa Parenteral Nutrition Market Size, Share and Trends Analysis Report by Nutrient Type (Carbohydrates, Parenteral Lipid Emulsion), Stage Type, Indication, Sales Channel 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The Middle East & Africa parenteral nutrition market size is expected to reach USD 346 million by 2030, registering a CAGR of 4.4%. The MEA parenteral nutrition market is expected to witness lucrative growth over the forecast period owing to various parameters such as presence of large pool of malnourished children, rising premature births, increasing adoption by healthcare settings for nutrient administration in chronically ill geriatric patients, and rising prevalence rate of cancer within the region. 
Increasing prevalence of chronic conditions such as cancer unswervingly influences the use of parenteral nutrition across the globe. Parenteral nutrition helps in the administration of key vital nutrients that are useful in maintaining strength, energy, and hydration level in cancer patients, thus, acting a vital impact rendering driver expected to surge market growth over the forecast period.
Similarly, predominant existence of malnourished children and premature neonates that require these nutrients, is expected to further propel the growth. According to statistics published by the Knoema, a public data platform, the prevalence of the malnutrition in Middle East and North Africa in 2013 was around 6.04%, however, it has witnessed a decline over the period of time.
Middle East & Africa Parenteral Nutrition Market Report Highlights
- Single dose amino acid solutions held a dominant share in 2023. This dominance is governed by the influx of innovative products. In addition, these innovative formulations are more efficient and cause lesser adverse effects.
- Intravenous lipid emulsions are anticipated to witness lucrative growth over the forecast period. Drug delivery through lipid emulsion is expected to showcase promising results as it results in minimal adverse effects such as irritation, pain, and thrombophlebitis.
- Adults dominated the market and accounted for 85.9% in 2023. The compromised gastrointestinal function, prolonged malnutrition, and increased malnutrition in adults drive the segmental growth.
- Cancer care dominated the market and accounted for a market share of 16.9% in 2023. It can be attributed to the rising cancer cases in the Middle East and African region.
- Institutional sales channels dominated the market and accounted for a market share of 49.2% in 2023. The large share of the segment can be attributed to the increasing allowance for the adoption of technologically advanced medical devices and parenteral nutrition solutions in settings such as hospitals and clinics.
The leading players in the Middle East & Africa Parenteral Nutrition market include:
- B. Braun Melsungen
- Baxter
- Fresenius Kabi
- Qatar Pharma Factory
- Hospira (now part of Pfizer Inc.)
- Evonik
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 80 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $256.5 Million |
| Forecasted Market Value (USD) by 2030 | $346 Million |
| Compound Annual Growth Rate | 4.4% |
| Regions Covered | Africa, Middle East |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. MEA Parenteral Nutrition Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.4. MEA Parenteral Nutrition Market Analysis Tools
Chapter 4. MEA Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. MEA Parenteral Nutrition Market: Nutrient Type Movement Analysis, USD Million, 2023 & 2030
4.3. Carbohydrates
4.4. Parenteral Lipid Emulsion
4.5. Single Dose Amino Acid Solution
4.6. Trace Elements
4.7. Vitamins & Minerals
Chapter 5. MEA Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. MEA Parenteral Nutrition Market: Stage Type Movement Analysis, USD Million, 2023 & 2030
5.3. Adult
5.4. Pediatric
Chapter 6. MEA Parenteral Nutrition Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. MEA Parenteral Nutrition Market: Indication Movement Analysis, USD Million, 2023 & 2030
6.3. Alzheimer's
6.4. Nutrition Deficiency
6.5. Cancer Care
6.6. Diabetes
6.7. Chronic Kidney Diseases
6.8. Orphan Diseases
6.9. Dysphagia
6.10. Pain Management
6.11. Malabsorption/GI Disorder/Diarrhea
6.12. Others
Chapter 7. MEA Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. MEA Parenteral Nutrition Market: Sales Channel Movement Analysis, USD Million, 2023 & 2030
7.3. Online Sales Channel
7.4. Retail Sales Channel
7.5. Institutional Sales Channel
Chapter 8. MEA Parenteral Nutrition Market: Regional Estimates & Trend Analysis
8.1. MEA Parenteral Nutrition Market Share, By Region, 2023 & 2030, USD Million
8.2. Middle East and Africa
8.2.2. South Africa
8.2.3. Saudi Arabia
8.2.4. UAE
8.2.5. Kuwait
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
- B. Braun Melsungen
- Baxter
- Fresenius Kabi
- Qatar Pharma Factory
- Hospira (now part of Pfizer Inc.)
- Evonik
For more information about this report visit https://www.researchandmarkets.com/r/271ymc
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
